repalid 2 mg tablett
specifar s.a. - repaglinid - tablett - 2 mg - glycerol hjälpämne; repaglinid 2 mg aktiv substans - repaglinid
ragespes 2 mg tablett
specifar s.a. - repaglinid - tablett - 2 mg - glycerol hjälpämne; repaglinid 2 mg aktiv substans - repaglinid
repicret 2 mg tablett
specifar s.a. - repaglinid - tablett - 2 mg - glycerol hjälpämne; repaglinid 2 mg aktiv substans - repaglinid
speraglin 2 mg tablett
specifar s.a. - repaglinid - tablett - 2 mg - glycerol hjälpämne; repaglinid 2 mg aktiv substans - repaglinid
aderegl 2 mg tablett
specifar s.a. - repaglinid - tablett - 2 mg - glycerol hjälpämne; repaglinid 2 mg aktiv substans - repaglinid
tecovirimat siga
siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirala medel för systemisk användning - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 och 5. tecovirimat siga should be used in accordance with official recommendations.
gemfibrozil sandoz 450 mg filmdragerad tablett
sandoz a/s - gemfibrozil - filmdragerad tablett - 450 mg - gemfibrozil 450 mg aktiv substans; laktosmonohydrat hjälpämne - gemfibrozil
gemfibrozil sandoz 600 mg filmdragerad tablett
sandoz a/s - gemfibrozil - filmdragerad tablett - 600 mg - laktosmonohydrat hjälpämne; gemfibrozil 600 mg aktiv substans - gemfibrozil
aubagio
sanofi winthrop industrie - teriflunomide - multipel skleros - selektiva immunsuppressiva medel - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - multipel skleros, skovvis förlöpande - immunsuppressiva - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).